Nasopharyngeal Carcinoma: all 824 studies
Page 8 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRTCompletedNCT01797900Phase 2
- Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal CarcinomaStatus unknownNCT01735409Phase 1/2
- Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNCT01728480Phase 1
- Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01712919Phase 1/2
- NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent ChemoradiationTerminatedNCT01694576Phase 2
- Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx CancerStatus unknownNCT01689558Phase 2/3
- Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyWithdrawnNCT01674374Phase 2
- GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01655628Phase 2
- Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
- Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal CarcinomaCompletedNCT01616849Phase 2
- Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal CancerStatus unknownNCT01614938Phase 2
- Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01612286Phase 2
- GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest ChinaCompletedNCT01596868Phase 2
- Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal CarcinomaCompletedNCT01540136Phase 3
- Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal CarcinomaStatus unknownNCT01536223Phase 3
- Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal CarcinomaCompletedNCT01534585Phase 1/2
- Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaCompletedNCT01528618Phase 3
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
- A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01479504Phase 3
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
- A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT01462903Phase 1
- Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT01462474Phase 1
- Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal CarcinomaCompletedNCT01449942Phase 1/2
- Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated DiseasesCompletedNCT01447056Phase 1
- Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01417390Phase 2
- SOX as Salvage Treatment in Nasopharyngeal CarcinomaTerminatedNCT01403259Phase 2
- Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT01392235Phase 2
- Assessment of New Radiation Oncology Technologies and TreatmentsCompletedNCT01379872
- MK-2206 in Recurrent Nasopharyngeal CarcinomaCompletedNCT01370070Phase 2
- New Approach of Assessing Drug Response for Treatment of Nasopharyngeal CancerCompletedNCT01365208
- Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement UltrasonographyStatus unknownNCT01347424Phase 2
- Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven TumorsStatus unknownNCT01341834Phase 1
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal CancerStatus unknownNCT01312311Phase 2
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal CarcinomaCompletedNCT01271439Phase 2
- Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal CarcinomaStatus unknownNCT01265147Phase 2
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck CancerTerminatedNCT01254734Not applicable
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post RadiotherapyStatus unknownNCT01237704Not applicable
- Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal CarcinomaTerminatedNCT01230476Phase 2
- The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal CarcinomaCompletedNCT01187238Phase 2
- Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC)Status unknownNCT01182909
- A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01171781Phase 2
- L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerCompletedNCT01155609Not applicable
- Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional TherapyCompletedNCT01094405Phase 2
- Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal CarcinomaStatus unknownNCT01086488Phase 2
- Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal CancerStatus unknownNCT01074021Phase 3
- 124I-FIAU Imaging in EBV and KSHV Associated CancersCompletedNCT00982449Not applicable
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T LymphocytesCompletedNCT00953420Phase 2
- A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal CancerStatus unknownNCT00943891
- Cluster Randomized Controlled Screening Trial for NPCStatus unknownNCT00941538Not applicable
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
- Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal CancersTerminatedNCT00828386Phase 3
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)Status unknownNCT00817583Phase 2
- Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal CarcinomaStatus unknownNCT00817258Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal CarcinomaStatus unknownNCT00816855Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal CarcinomaStatus unknownNCT00816816Phase 2
- Photon/Proton Radiation Therapy for Carcinoma of the NasopharynxTerminatedNCT00797290
- Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT00778908Phase 2/3
- Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
- A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal CarcinomaCompletedNCT00717184Phase 1
- Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal CancerCompletedNCT00706316Phase 1
- A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT00705627Phase 3
- Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00697905Phase 2
- Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT00677118Phase 3
- Trial of E10A in Head and Neck CancerStatus unknownNCT00634595Phase 2
- Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapyCompletedNCT00630149Phase 2
- T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPCCompletedNCT00609219Phase 1
- Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal CancerStatus unknownNCT00577057Not applicable
- Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)Status unknownNCT00563927Not applicable
- Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)TerminatedNCT00563862Not applicable
- Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CACompletedNCT00535795Phase 3
- LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)CompletedNCT00516087Phase 1
- Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)WithdrawnNCT00515957Phase 1
- Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal CarcinomaTerminatedNCT00484601Phase 2
- Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
- A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.CompletedNCT00439426Phase 2
- Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00436800Phase 2
- Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNCT00436293Phase 2
- Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaCompletedNCT00431210Phase 1
- Acupuncture for Prevention of Radiation-Induced XerostomiaCompletedNCT00430378Not applicable
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC FamiliesTerminatedNCT00393224
- Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal CarcinomaCompletedNCT00379262Phase 3
- A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following RadiotherapyCompletedNCT00370890Phase 3
- Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal CarcinomaWithdrawnNCT00367718Phase 2
- Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC PatientsStatus unknownNCT00364962
- Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT00363831Phase 2
- Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)CompletedNCT00341146
- Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00305734Phase 2
- Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC PatientsStatus unknownNCT00304694
- A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2
- A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
- A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma PatientsTerminatedNCT00201344Phase 3
- Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.CompletedNCT00188253
- Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal CarcinomaWithdrawnNCT00181220Phase 1